{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:58:58Z","timestamp":1790456338344,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08095-8","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T01:40:57Z","timestamp":1745890857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Amphiphilic mPEG-PLGA copolymer nanoparticles co-delivering colistin and niclosamide to treat colistin-resistant Gram-negative bacteria infections"],"prefix":"10.1038","volume":"8","author":[{"given":"Kaifang","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7042-5771","authenticated-orcid":false,"given":"Gongzheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"8095_CR1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S1473-3099(18)30611-X","volume":"18","author":"K LaPlante","year":"2018","unstructured":"LaPlante, K., Cusumano, J. & Tillotson, G. Colistin for the treatment of multidrug-resistant infections. Lancet Infect. Dis. 18, 1174\u20131175 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"8095_CR2","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1016\/S1473-3099(18)30119-1","volume":"18","author":"M Mendelson","year":"2018","unstructured":"Mendelson, M. et al. The One Health stewardship of colistin as an antibiotic of last resort for human health in South Africa. Lancet Infect. Dis. 18, e288\u2013e294 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"8095_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YY Liu","year":"2016","unstructured":"Liu, Y. Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16, 161\u2013168 (2016).","journal-title":"Lancet Infect Dis"},{"key":"8095_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fmicb.2020.00798","volume":"11","author":"Y Choi","year":"2020","unstructured":"Choi, Y. et al. Comparison of fitness cost and virulence in chromosome- and plasmid-mediated colistin-resistant Escherichia coli. Front. Microbiol. 11, 798 (2020).","journal-title":"Front. Microbiol."},{"key":"8095_CR5","doi-asserted-by":"crossref","unstructured":"Xu, Y. et al. An Evolutionarily conserved mechanism for intrinsic and transferable polymyxin resistance. mBio 9, 2 (2018).","DOI":"10.1128\/mBio.02317-17"},{"key":"8095_CR6","doi-asserted-by":"crossref","unstructured":"Andrade, F. F., Silva, D., Rodrigues, A. & Pina-Vaz, C. Colistin update on its mechanism of action and resistance, present and future challenges. Microorganisms 8, 11 (2020).","DOI":"10.3390\/microorganisms8111716"},{"key":"8095_CR7","doi-asserted-by":"publisher","first-page":"e0145839","DOI":"10.1371\/journal.pone.0145839","volume":"11","author":"T Hald","year":"2016","unstructured":"Hald, T. et al. World health organization estimates of the relative contributions of food to the burden of disease due to selected foodborne hazards: a structured expert elicitation. PLoS ONE 11, e0145839 (2016).","journal-title":"PLoS ONE"},{"key":"8095_CR8","doi-asserted-by":"crossref","unstructured":"Copp, J. N. et al. Mechanistic understanding enables the rational design of salicylanilide combination therapies for gram-negative infections. mBio 11, 5 (2020).","DOI":"10.1128\/mBio.02068-20"},{"key":"8095_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fcimb.2018.00348","volume":"8","author":"R Ayerbe-Algaba","year":"2018","unstructured":"Ayerbe-Algaba, R. et al. Synergistic activity of niclosamide in combination with colistin against colistin-susceptible and colistin-resistant acinetobacter baumannii and Klebsiella pneumoniae. Front. Cell Infect. Microbiol. 8, 348 (2018).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"8095_CR10","doi-asserted-by":"crossref","unstructured":"Domalaon, R., De Silva, P. M., Kumar, A., Zhanel, G. G. & Schweizer, F. The anthelmintic drug niclosamide synergizes with colistin and reverses colistin resistance in gram-negative bacilli. Antimicrob. Agents Chemother. 63, 4 (2019).","DOI":"10.1128\/AAC.02574-18"},{"key":"8095_CR11","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.3892\/mmr.2017.6768","volume":"16","author":"LX Zhang","year":"2017","unstructured":"Zhang, L. X. et al. Niclosamide attenuates inflammatory cytokines via the autophagy pathway leading to improved outcomes in renal ischemia\/reperfusion injury. Mol. Med. Rep. 16, 1810\u20131816 (2017).","journal-title":"Mol. Med. Rep."},{"key":"8095_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-380","volume":"13","author":"L Sorl\u00ed","year":"2013","unstructured":"Sorl\u00ed, L. et al. Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study. BMC Infect. Dis. 13, 380 (2013).","journal-title":"BMC Infect. Dis."},{"key":"8095_CR13","doi-asserted-by":"crossref","unstructured":"Forrest, A. et al. Pharmacokinetic\/toxicodynamic analysis of colistin-associated acute kidney injury in critically Ill patients. Antimicrob. Agents Chemother. 61, 11 (2017).","DOI":"10.1128\/AAC.01367-17"},{"key":"8095_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ijantimicag.2016.09.010","volume":"48","author":"TB Tran","year":"2016","unstructured":"Tran, T. B. et al. Pharmacokinetics\/pharmacodynamics of colistin and polymyxin B: are we there yet? Int. J. Antimicrob. Agents 48, 592\u2013597 (2016).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"8095_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2174\/138920021131400105","volume":"14","author":"BE Grottkau","year":"2013","unstructured":"Grottkau, B. E., Cai, X., Wang, J., Yang, X. & Lin, Y. Polymeric nanoparticles for a drug delivery system. Curr. Drug Metab. 14, 840\u2013846 (2013).","journal-title":"Curr. Drug Metab."},{"key":"8095_CR16","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","volume":"32","author":"J Guo","year":"2011","unstructured":"Guo, J. et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32, 8010\u20138020 (2011).","journal-title":"Biomaterials"},{"key":"8095_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier, F. et al. PLGA-based nanoparticles: an overview of biomedical applications. J. Control Release 161, 505\u2013522 (2012).","journal-title":"J. Control Release"},{"key":"8095_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0378-5173(03)00224-2","volume":"259","author":"K Avgoustakis","year":"2003","unstructured":"Avgoustakis, K. et al. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int. J. Pharm. 259, 115\u2013127 (2003).","journal-title":"Int. J. Pharm."},{"key":"8095_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/bip.21013","volume":"90","author":"Y Chen","year":"2008","unstructured":"Chen, Y., Wang, F. & Benson, H. A. Effect of formulation factors on incorporation of the hydrophilic peptide dalargin into PLGA and mPEG-PLGA nanoparticles. Biopolymers 90, 644\u2013650 (2008).","journal-title":"Biopolymers"},{"key":"8095_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.nano.2009.02.002","volume":"5","author":"J Park","year":"2009","unstructured":"Park, J. et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine 5, 410\u2013418 (2009).","journal-title":"Nanomedicine"},{"key":"8095_CR21","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.1166\/jnn.2020.18756","volume":"20","author":"Y Lin","year":"2020","unstructured":"Lin, Y., Zhuang, X., Xie, B. & Chen, H. Enhanced antitumor efficacy of docetaxel-loaded monomethoxy Poly(ethylene glycol)-Poly(D, L-lactide-co-glycolide) amphiphilic copolymer against non-small cell lung cancer. J. Nanosci. Nanotechnol. 20, 7263\u20137270 (2020).","journal-title":"J. Nanosci. Nanotechnol."},{"key":"8095_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0168-3659(01)00535-1","volume":"79","author":"K Pays","year":"2002","unstructured":"Pays, K., Giermanska-Kahn, J., Pouligny, B., Bibette, J. & Leal-Calderon, F. Double emulsions: how does release occur? J. Control Release 79, 193\u2013205 (2002).","journal-title":"J. Control Release"},{"key":"8095_CR23","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.1016\/j.biomaterials.2011.07.032","volume":"32","author":"H Wang","year":"2011","unstructured":"Wang, H. et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 32, 8281\u20138290 (2011).","journal-title":"Biomaterials"},{"key":"8095_CR24","doi-asserted-by":"crossref","unstructured":"Mahmoud, B. S. & McConville, C. Box-Behnken design of experiments of polycaprolactone nanoparticles loaded with irinotecan hydrochloride. Pharmaceutics 15, 4 (2023).","DOI":"10.3390\/pharmaceutics15041271"},{"key":"8095_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/02652048.2018.1462416","volume":"35","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers. J. Microencapsul. 35, 241\u2013248 (2018).","journal-title":"J. Microencapsul."},{"key":"8095_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nmat1737","volume":"5","author":"Y Wang","year":"2006","unstructured":"Wang, Y., Gao, S., Ye, W. H., Yoon, H. S. & Yang, Y. Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat. Mater. 5, 791\u2013796 (2006).","journal-title":"Nat. Mater."},{"key":"8095_CR27","doi-asserted-by":"publisher","first-page":"9986","DOI":"10.1021\/acsnano.5b03521","volume":"9","author":"Y Jiang","year":"2015","unstructured":"Jiang, Y. et al. The interplay of size and surface functionality on the cellular uptake of sub-10 nm gold nanoparticles. ACS Nano 9, 9986\u20139993 (2015).","journal-title":"ACS Nano"},{"key":"8095_CR28","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/anie.201002969","volume":"50","author":"AS Karakoti","year":"2011","unstructured":"Karakoti, A. S., Das, S., Thevuthasan, S. & Seal, S. PEGylated inorganic nanoparticles. Angew. Chem. Int. Ed. Engl. 50, 1980\u20131994 (2011).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"8095_CR29","doi-asserted-by":"publisher","first-page":"10064","DOI":"10.1073\/pnas.1901730116","volume":"116","author":"Y Hong","year":"2019","unstructured":"Hong, Y., Zeng, J., Wang, X., Drlica, K. & Zhao, X. Post-stress bacterial cell death mediated by reactive oxygen species. Proc. Natl. Acad. Sci. USA 116, 10064\u201310071 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8095_CR30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.celrep.2015.09.059","volume":"13","author":"P Belenky","year":"2015","unstructured":"Belenky, P. et al. Bactericidal antibiotics induce toxic metabolic perturbations that lead to cellular damage. Cell Rep. 13, 968\u2013980 (2015).","journal-title":"Cell Rep."},{"key":"8095_CR31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1080\/17512433.2021.1933436","volume":"14","author":"F Jafari","year":"2021","unstructured":"Jafari, F. & Elyasi, S. Prevention of colistin induced nephrotoxicity: a review of preclinical and clinical data. Expert Rev. Clin. Pharmacol. 14, 1113\u20131131 (2021).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"8095_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00213-21","volume":"59","author":"R Humphries","year":"2021","unstructured":"Humphries, R., Bobenchik, A. M., Hindler, J. A. & Schuetz, A. N. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st Edition. J. Clin. Microbiol. 59, e0021321 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"8095_CR33","doi-asserted-by":"publisher","first-page":"8670","DOI":"10.1021\/la701067r","volume":"23","author":"S Kang","year":"2007","unstructured":"Kang, S., Pinault, M., Pfefferle, L. D. & Elimelech, M. Single-walled carbon nanotubes exhibit strong antimicrobial activity. Langmuir 23, 8670\u20138673 (2007).","journal-title":"Langmuir"},{"key":"8095_CR34","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41564-020-0723-z","volume":"5","author":"M Song","year":"2020","unstructured":"Song, M. et al. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens. Nat. Microbiol. 5, 1040\u20131050 (2020).","journal-title":"Nat. Microbiol."},{"key":"8095_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nchembio.1710","volume":"11","author":"H Hamamoto","year":"2015","unstructured":"Hamamoto, H. et al. Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. Nat. Chem. Biol. 11, 127\u2013133 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"8095_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112873","volume":"149","author":"K Yi","year":"2022","unstructured":"Yi, K. et al. Synergistic antibacterial activity of tetrandrine combined with colistin against MCR-mediated colistin-resistant Salmonella. Biomed. Pharmacother. 149, 112873 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"8095_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201902227","volume":"7","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Metformin restores tetracyclines susceptibility against multidrug resistant bacteria. Adv. Sci. (Weinh) 7, 1902227 (2020).","journal-title":"Adv. Sci. (Weinh)"},{"key":"8095_CR38","doi-asserted-by":"publisher","first-page":"15411","DOI":"10.1021\/acsnano.3c00981","volume":"17","author":"H Zhao","year":"2023","unstructured":"Zhao, H. et al. Antibiotic-polymer self-assembled nanocomplex to reverse phenotypic resistance of bacteria toward last-resort antibiotic colistin. ACS Nano 17, 15411\u201315423 (2023).","journal-title":"ACS Nano"},{"key":"8095_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-60327-198-1_23","volume":"697","author":"BW Neun","year":"2011","unstructured":"Neun, B. W. & Dobrovolskaia, M. A. Method for analysis of nanoparticle hemolytic properties in vitro. Methods Mol. Biol. 697, 215\u2013224 (2011).","journal-title":"Methods Mol. Biol."},{"key":"8095_CR40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.actbio.2022.11.055","volume":"157","author":"Q Tang","year":"2023","unstructured":"Tang, Q. et al. Hydrophobic modification improves the delivery of cell-penetrating peptides to eliminate intracellular pathogens in animals. Acta Biomater. 157, 210\u2013224 (2023).","journal-title":"Acta Biomater."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08095-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08095-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T01:41:00Z","timestamp":1745890860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08095-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8095"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08095-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"3 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"673"}}